Skip to main content

Davis Polk & Wardwell and Global Law Office are advising medical research firm CARsgen Therapeutics on its planned IPO in Hong Kong, with Herbert Smith Freehills and Zhong Lun Law Firm advising the joint underwriters. The IPO is expected to raise up to $400 million.

CARsgen is a biopharmaceutical company established in 2014, with operations in China and the U.S. It focuses on CAR-T cell therapies for the treatment of hematological malignancies and solid tumors.

Maples and Calder is providing the issuer offshore legal advice. The joint underwriters are Goldman Sachs and UBS.

Related Articles

Deals

AZB, Kirkland, Trilegal act on Bain Capital’s first India bet in 2025

by Nimitt Dixit |

AZB & Partners and Kirkland & Ellis have guided Bain Capital’s investment into Indian automotive component maker Dhoot Transmission Group, which was represented by Trilegal.

Deals

CC, DFDL, Bakers, HBS act on $550 mln Cambodia microfinance deal

by Asian Legal Business《亚洲法律杂志》 |

Magic Circle law firm Clifford Chance and DFDL have advised a consortium of investors on the $550 million sale of Cambodian microfinance institution Amret to Taiwan's Bank SinoPac, which was represented by Baker McKenzie Taiwan and local firm HBS Law.

Deals

A&O Shearman guides $1.2 bln Malaysian data centre deal

by Nimitt Dixit |

Global law firm A&O Shearman has advised Malaysian real estate firm Sime Darby Property (SDP) on a $1.2 billion agreement to develop and lease a data centre campus in Malaysia with Google-backed Pearl Computing Malaysia.